Yung Cheng Wu

Yung Cheng Wu is a declared insider of Antibe Therapeutics Inc., with filings sourced from SEDI. In total, 31 filings cover trades dated from 18 July 2016 to 11 January 2024.

Purchases make up the whole of the open-market record (8 purchases, €58k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 14 option exercises.

Half of the purchases are above €3,781 and half below. No cluster: in 8 purchases, no other insider of the company bought within 30 days.

The latest filing, published on 13 January 2024, reports an option exercise of €9,716 in Antibe Therapeutics Inc. The last purchase on record was published on 3 November 2021, which is 1,817 days ago. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.